HomeIDRSF • OTCMKTS
add
Idorsia Ltd
Previous close
$2.59
Day range
$1.30 - $1.35
Year range
$1.30 - $4.70
Market cap
216.56M CHF
Avg Volume
350.00
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
Market news
Financials
Income Statement
Revenue
Net income
(CHF) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 16.35M | -45.38% |
Operating expense | 72.51M | -41.73% |
Net income | -108.57M | 43.78% |
Net profit margin | -664.18 | -2.94% |
Earnings per share | — | — |
EBITDA | -90.86M | 47.81% |
Effective tax rate | -0.23% | — |
Balance Sheet
Total assets
Total liabilities
(CHF) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 248.00M | 466.41% |
Total assets | 670.06M | 26.96% |
Total liabilities | 1.71B | 9.17% |
Total equity | -1.04B | — |
Shares outstanding | 180.04M | — |
Price to book | -0.45 | — |
Return on assets | -32.77% | — |
Return on capital | -86.82% | — |
Cash Flow
Net change in cash
(CHF) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -108.57M | 43.78% |
Cash from operations | -97.21M | 49.38% |
Cash from investing | -260.00K | 91.43% |
Cash from financing | -80.00K | -100.27% |
Net change in cash | -97.66M | 41.70% |
Free cash flow | -76.52M | 45.76% |
About
Idorsia is a Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland. Wikipedia
Founded
2017
Website
Employees
938